Dermatologic Manifestations of Albinism Differential Diagnoses

1. Chiang PW, Spector E, Tsai AC. Oculocutaneous albinism spectrum. Am J Med Genet A. 2009 Jul. 149A(7):1590-1. [QxMD MEDLINE Link].

2. Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009 Sep. 18(9):741-9. [QxMD MEDLINE Link].

3. Oetting WS, Brilliant MH, King RA. The clinical spectrum of albinism in humans. Mol Med Today. 1996 Aug. 2(8):330-5. [QxMD MEDLINE Link].

4. Oetting WS, King RA. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat. 1999. 13(2):99-115. [QxMD MEDLINE Link].

5. Huizing M, Malicdan MCV, Gochuico BR, Gahl WA. Hermansky-Pudlak Syndrome. Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. Seattle, Wash: University of Washington; 2017 Oct 26. [Full Text].

6. Kubasch AS, Meurer M. [Oculocutaneous and ocular albinism]. Hautarzt. 2017 Nov. 68 (11):867-875. [QxMD MEDLINE Link].

7. Hayashi M, Suzuki T. Oculocutaneous Albinism Type 4. Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. September 7, 2017. Seattle, Wash: University of Washington; 2017 September 7. [Full Text].

8. Ray K, Chaki M, Sengupta M. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1. Prog Retin Eye Res. 2007 Jul. 26(4):323-58. [QxMD MEDLINE Link].

9. Rooryck C, Morice-Picard F, Elcioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell Melanoma Res. 2008 Oct. 21(5):583-7. [QxMD MEDLINE Link].

10. Zuhlke C, Criee C, Gemoll T, Schillinger T, Kaesmann-Kellner B. Polymorphisms in the genes for oculocutaneous albinism type 1 and type 4 in the German population. Pigment Cell Res. 2007 Jun. 20(3):225-7. [QxMD MEDLINE Link].

11. Suzuki T, Tomita Y. Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. J Dermatol Sci. 2008 Jul. 51(1):1-9. [QxMD MEDLINE Link].

12. Forshew T, Khaliq S, Tee L, et al. Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism. Clin Genet. 2005 Aug. 68(2):182-4. [QxMD MEDLINE Link].

13. Kamaraj B, Purohit R. Mutational analysis of oculocutaneous albinism: a compact review. Biomed Res Int. 2014. 2014:905472. [QxMD MEDLINE Link].

14. Hutton SM, Spritz RA. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients. Invest Ophthalmol Vis Sci. 2008 Mar. 49(3):868-72. [QxMD MEDLINE Link].

15. Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol. 2008 Jan. 15(1):22-9. [QxMD MEDLINE Link].

16. Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res. 2006 Feb. 19(1):19-42. [QxMD MEDLINE Link].

17. Menasche G, Fischer A, de Saint Basile G. Griscelli syndrome types 1 and 2. Am J Hum Genet. 2002 Nov. 71(5):1237-8; author reply 1238. [QxMD MEDLINE Link]. [Full Text].

18. Pujani M, Agarwal K, Bansal S, Ahmad I, Puri V, Verma D, et al. Chediak-Higashi syndrome - a report of two cases with unusual hyperpigmentation of the face. Turk Patoloji Derg. 2011. 27(3):246-8. [QxMD MEDLINE Link].

19. Roy A, Kar R, Basu D, Srivani S, Badhe BA. Clinico-hematological profile of Chediak-Higashi syndrome: experience from a tertiary care center in south India. Indian J Pathol Microbiol. 2011 Jul-Sep. 54(3):547-51. [QxMD MEDLINE Link].

20. Lin YY, Wei AH, He X, Zhou ZY, Lian S, Zhu W. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene. Eur J Dermatol. 2014 Mar-Apr. 24(2):168-73. [QxMD MEDLINE Link].

21. Hida T, Okura M, Tanaka T, Yamashita T. A case of oculocutaneous albinism type 4: aberrant expression of SLC45A2 transcript with exon skipping. J Dermatol. 2014 Oct 9. [QxMD MEDLINE Link].

22. Minakawa S, Kaneko T, Matsuzaki Y, Akasaka E, Mizukami H, Abe Y, et al. Case of oculocutaneous albinism complicated with squamous cell carcinoma, Bowen's disease and actinic keratosis. J Dermatol. 2014 Sep. 41(9):863-4. [QxMD MEDLINE Link].

23. Chatterjee K, Rasool F, Chaudhuri A, Chatterjee G, Sehgal VN, Singh N. Basal cell carcinoma, oculo-cutaneous albinism and actinic keratosis in a native Indian. Indian J Dermatol. 2013 Sep. 58(5):377-9. [QxMD MEDLINE Link]. [Full Text].

24. Carden SM, Boissy RE, Schoettker PJ, Good WV. Albinism: modern molecular diagnosis. Br J Ophthalmol. 1998 Feb. 82(2):189-95. [QxMD MEDLINE Link].

25. King RA, Hearing VJ, Creel DJ. Albinism. Scriver CR, Beaudet AL, Sly WS, Valle DL, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995. Vol 3: 4353-92.

Raymond E Boissy, PhD Director of Basic Science Research, Professor, Departments of Dermatology and Cell Biology, University of Cincinnati College of Medicine

Raymond E Boissy, PhD is a member of the following medical societies: Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Van Perry, MD Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas School of Medicine at San Antonio

Van Perry, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Jean Paul Ortonne, MD Chair, Department of Dermatology, Professor, Hospital L'Archet, Nice University, France

Jean Paul Ortonne, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

James J Nordlund, MD Professor Emeritus, Department of Dermatology, University of Cincinnati College of Medicine

James J Nordlund, MD is a member of the following medical societies: American Academy of Dermatology, Sigma Xi, The Scientific Research Honor Society, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article